| 000 | 01889 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517130204.0 | ||
| 264 | 0 | _c20171026 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1479-6813 | ||
| 024 | 7 |
_a10.1530/JME-16-0134 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShen, Chen-Tian | |
| 245 | 0 | 0 |
_aMetformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo. _h[electronic resource] |
| 260 |
_bJournal of molecular endocrinology _c01 2017 |
||
| 300 |
_a15-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarcinoma, Papillary _xdiagnostic imaging |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aGlucose Transporter Type 1 _xgenetics |
| 650 | 0 | 4 | _aHeterografts |
| 650 | 0 | 4 |
_aHexokinase _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aMetabolic Networks and Pathways _xdrug effects |
| 650 | 0 | 4 |
_aMetformin _xpharmacology |
| 650 | 0 | 4 |
_aPositron Emission Tomography Computed Tomography _xmethods |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xmetabolism |
| 650 | 0 | 4 | _aThyroid Cancer, Papillary |
| 650 | 0 | 4 |
_aThyroid Neoplasms _xdiagnostic imaging |
| 700 | 1 | _aWei, Wei-Jun | |
| 700 | 1 | _aQiu, Zhong-Ling | |
| 700 | 1 | _aSong, Hong-Jun | |
| 700 | 1 | _aZhang, Xin-Yun | |
| 700 | 1 | _aSun, Zhen-Kui | |
| 700 | 1 | _aLuo, Quan-Yong | |
| 773 | 0 |
_tJournal of molecular endocrinology _gvol. 58 _gno. 1 _gp. 15-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1530/JME-16-0134 _zAvailable from publisher's website |
| 999 |
_c26668867 _d26668867 |
||